TY  - CHAP
M1  - Book, Section
TI  - Antituberculous Medications
A1  - Gruenberg, Katherine
A1  - Guglielmo, B. Joseph
A2  - Papadakis, Maxine A.
A2  - McPhee, Stephen J.
A2  - Rabow, Michael W.
A2  - McQuaid, Kenneth R.
PY  - 2023
T2  - Current Medical Diagnosis & Treatment 2023
AB  - Mycobacteria  are  intracellular,  have  long  periods  of  metabolic  inactivity,  and  tend  to  develop  resistance  to  any  one  medication.  Therefore,  combined  medication  therapy  is  used  to  delay  the  emergence  of  resistance.  First-line  medications,  increasingly  used  together  in  the  treatment  of  tuberculosis,  are  isoniazid,  ethambutol,  rifampin,  and  pyrazinamide.  
SN  - 
PB  - McGraw-Hill Education
CY  - New York, NY
Y2  - 2024/10/12
UR  - accessmedicine.mhmedical.com/content.aspx?aid=1193122099
ER  -